Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder
Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder
The primary objective is to compare the antidepressant efficacy, safety, and tolerability of
 DVS SR versus placebo in subjects with Major Depressive Disorder. Additional objectives
 include testing both general and functional quality-of-life outcomes and satisfaction with
 therapy reported by the subject.
Inclusion Criteria:

 -  A primary diagnosis of MDD

 -  Depressive symptoms for at least 30 days before the screening visit.

 Exclusion Criteria:

 -  Treatment with DVS SR at any time in the past.

 -  Known hypersensitivity to venlafaxine

 -  Significant risk of suicide based on clinical judgment